Podcasts about american society

"Doc, do I need to take this forever?" It's one of the most common questions I hear in my office, whether it's someone's very first visit or someone who's already lost 30, 40, even 80 pounds and is feeling great. In this episode, I break down why your body fights so hard to regain weight after you lose it, and why that's biology, not failure. I walk through the new ATTAIN Maintain trial, a study of 376 adults who had already lost significant weight on tirzepatide or semaglutide, testing whether switching to an easier once-daily oral GLP-1 could help them keep the weight off, instead of just asking whether stopping medication causes regain. Maintenance isn't about staying on one medication forever. It's about having an individualized, active plan, and the ATTAIN Maintain data gives us more options than ever to build one. Episode Highlights: Why your metabolism and hunger hormones fight to reverse weight loss Lessons from the SURMOUNT-4 trial on what happens when treatment stops completely Inside the ATTAIN Maintain trial design and who was studied The weight maintenance results: oral medication vs. placebo Why maintenance therapy doesn't have to look like the treatment that got you there What actually goes into a sustainable long-term plan beyond medication Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of industry-shaping events, reflecting the ever-evolving landscape of drug development, regulatory challenges, and strategic maneuvers. In a significant move within the sector, Jasper Therapeutics has merged with Kira Pharmaceuticals, a strategic decision aimed at expanding its footprint in autoimmune therapeutics. This merger brings to Jasper a valuable asset in KP-104, a dual-inhibitor with the potential to address rare diseases—an area of considerable unmet need. Such consolidations highlight an industry trend where companies seek to bolster their portfolios with promising candidates that can tackle complex medical conditions. The merger exemplifies how strategic expansions are becoming increasingly integral to maintaining competitive edges in the biotech arena. Turning to clinical trials, Takeda's Zasocitinib has demonstrated promising results for patients suffering from moderate-to-severe plaque psoriasis. In Phase 3 trials, a significant 75% of patients achieved clearance of scalp psoriasis. Zasocitinib operates as a TYK2 inhibitor, targeting the IL-23 pathway—a crucial mechanism in autoimmune diseases like psoriasis. This breakthrough promises to enhance patient care by providing a more effective treatment option for those struggling with difficult-to-treat psoriasis. On the regulatory front, Novartis' Fabhalta (Iptacopan) has gained FDA approval for its role in slowing kidney function decline in patients with primary immunoglobulin A nephropathy. As a small molecule complement inhibitor, Iptacopan introduces a novel treatment class for this autoimmune kidney disorder. This approval underscores ongoing innovation within nephrology and offers renewed hope for improved patient outcomes. Recent regulatory updates also saw Novartis securing full FDA approval for Fabhalta—an affirmation of progress in addressing immunoglobulin A nephropathy through innovative therapeutic options. Business development remains a driving force in shaping industry landscapes. The acquisition of Mission Therapeutics' AKI candidate MTX652 by Dimerix is a prime example. This $5 million deal, with potential milestones up to $292 million, reflects high stakes and ambitions to advance treatments for acute kidney injuries—a field with significant unmet medical needs. The integration of artificial intelligence continues to revolutionize drug discovery processes. Aqemia's collaboration with Sanofi highlights this trend, showcasing AI's crucial role in expediting drug development and uncovering novel therapeutic targets. Their partnership potentially worth $140 million underscores AI's transformative potential within pharmaceutical research. Notably, Nobel laureate Jennifer Doudna's foray into AI-powered protein design signifies an exciting intersection between gene-editing technology and artificial intelligence. Her involvement signals potential revolutions in drug discovery through enhanced precision in protein engineering. However, regulatory challenges persistently loom over the industry. Novo Nordisk and Alvotech have faced FDA scrutiny concerning manufacturing deficiencies—an issue that accentuates the importance of stringent quality control and operational excellence in biologics manufacturing. The American Society of Health-System Pharmacists (ASHP) report on U.S. drug shortages during Q2 2026 reveals vulnerabilities within supply chains, notably impacting oncology drugs. These shortages emphasize the critical need for robust strategies to ensure consistent drug availability for essential therapies. Furthermore, geopolitical dynamics are influencing pharmaceutical supply chains. A U.S. Senate bill aimed at increasing transparency highlights concerns over China's dominance in drug ingredient supplies—an issue necessitating strategic adjustments by globally operating companies. Elsewhere within the sector, GSK made headlines by discontinuing the development of its chronic cough treatment camlipixant following mixed Phase 3 trial results—a setback illustrating the critical nature of trial outcomes in determining drug viability and market potential. In market trends, biotech IPOs have surged during the first half of 2026—a sign of robust investor interest fueled by innovations and favorable funding environments despite associated market volatility risks. Strategic adjustments continue across companies with mergers and acquisitions leading to workforce reductions—projected layoffs exceeding 14,000 within biopharma during H1 2026—as organizations streamline operations or pivot towards more promising research domains. Lastly, Merck's FDA approval for an oral PCSK9 inhibitor marks a significant achievement in cardiovascular care—representing another stride forward in therapeutic innovation. In summary, these developments encapsulate a landscape defined by scientific pursuits yielding mixed results amidst evolving regulatory interactions and strategic realignments—all contributing towards innovative healthcare solutions while navigating complex industry dynamics.Support the show

In this episode of the DermSurgery Digest, you'll hear quick, high-yield summaries with practical takeaways on the cosmetic and general dermatology articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors this month are Ardalan Minokadeh, MD, PhD, and Kristel Polder, MD.This podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining cosmetic and general dermatology articles from the July issue are highlighted in-depth in a companion episode, Spotlight, published on July 10, 2026.We welcome your feedback. Please contact communicationstaff@asds.net.

In this episode of the DermSurgery Digest, you'll hear quick, high-yield summaries with practical takeaways on the surgical oncology and reconstruction articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors this month are Kyle Lauck, MD, and Ally-Khan Somani, MD, PhD, EMBA.This podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining surgical oncology and reconstruction articles from the July issue are highlighted in-depth in a companion episode, Spotlight, published on July 10, 2026.We welcome your feedback. Please contact communicationstaff@asds.net.

"Lethal and sublethal effects of novaluron, a novel insect growth regulator, on annual bluegrass weevil, Listronotus maculicollis Kirby, lifestages in turfgrass" with Benjamin A McGraw. Today we'll be talking to Dr. Benjamin McGraw. Annual bluegrass weevil or ABW is a pest that preys on golf course turf. Novaluron is a new pesticide that may be able to help control ABW, but how does it work and at which life stages is it most effective? In this episode, Benjamin joins me to discuss his work studying novaluron. If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/csc2.70042 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Ben, you can find him here: bam53@psu.edu Resources Penn State Turf: https://plantscience.psu.edu/research/centers/turf Penn State Turf X: https://x.com/psuplantscience Penn State Turf Instagram: https://www.instagram.com/psuplantscience/ CEU Quiz: https://web.sciencesocieties.org/Learning-Center/Courses/Course-Detail?productid=%7bBFDA7038-5981-F111-AB0E-70A8A59D1B85%7d  Transcripts: Coming soon Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.

Greg Watkins-Colwell is Senior Collection Manager of Herpetology and Ichthyology at the Yale Peabody Museum, where his work spans natural history collections, systematics, biogeography, research, and public education. He also serves on the Board of Governors of the American Society of Ichthyologists and Herpetologists and the Science Advisory Board of Connecticut's Beardsley Zoo.

Highlights from the PER® CME activity "Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2− Metastatic Breast Cancer–What the Latest Data Really Tell Us" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.In this podcast, experts Virginia Kaklamani, MD, DSc; Kamel Abou Hussein, MD; Javier Cortés, MD, PhD; and Seth A. Wander, MD, PhD, discuss American Society of Clinical Oncology (ASCO) 2026 updates about data for oral selective estrogen receptor degraders (SERDs) to treat metastatic, HR-positive breast cancer.Earn CME credit by completing the full accredited activity (available through June 29, 2027): https://www.gotoper.com/courses/oncology-town-hall-updates-from-chicago-oral-serds-in-hrher2-metastatic-breast-cancerwhat-the-latest-data-really-tell-us This podcast, including the narration, was developed by PER® (Physicians' Education Resource®, LLC) editorial staff from the full online CME activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool. The podcast contains no product advertising. The full activity is supported by an educational grant from Stemline Therapeutics, Inc.This content is for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Faculty may discuss investigational or off-label uses; consult prescribing information for any products discussed.

We welcome back John Horvat II of the American Society for the Defense of Tradition, Family and Property to examine the meaning of proclaiming "Christ is King" in an increasingly secular culture. What changes when Christ's authority is no longer recognized in public life or even within the Church? Father finishes with Timely Thoughts.  Show Notes Christ is King, No Matter Who says It or Not Why Modern Law Clashes with the Social Kingship of Our Lord Jesus Christ Quas Primas iCatholic Mobile The Station of the Cross Merchandise - Use Coupon Code 14STATIONS for 10% off | Catholic to the Max Read Fr. McTeigue's Written Works! "Let's Take A Closer Look" with Fr. Robert McTeigue, S.J. | Full Series Playlist Listen to Fr. McTeigue's Preaching! | Herald of the Gospel Sermons Podcast on Spotify Visit Fr. McTeigue's Website | Herald of the Gospel Questions? Comments? Feedback? Ask Father!

The fertilization report looked good. You had eggs. They fertilized. Day three looked fine. Then came the call. Nothing made it past day five, or one did, and it was graded poor, and the cycle was over. You were told it was egg quality, or it was a numbers game, or that you have to try again. Here is what that explanation leaves out. An embryo does not run on one engine the whole way. For the first two to three days it runs almost entirely on the egg, on the proteins, the messenger molecules, and the energy the egg packed during its final growth phase. Then, around the four to eight cell stage on day three, the embryo activates its own genome and takes over, and the paternal contribution comes online. That handover changes where you look. If development stalls in the first three days, you start with the egg and its energy supply. If it looked strong on day three and stalled before the blastocyst, you start with the sperm and its DNA. Same line in the report. Two completely different first moves. Most workups examine neither. They adjust the protocol and go again. In this episode, I walk through the seven factors that shape whether an embryo keeps dividing, and what most clinics never review before they tell you it was your eggs. Pull it up, take notes, and bring it to your next appointment. TIMESTAMPS 00:00 The day five call and what the explanation leaves out 00:55 If this show has helped you, leave a review 01:05 Who reviews your case at Fab Fertile 03:50 Number one: the day three handover and where to look first 06:10 Number two: the egg's energy supply was built before the cycle 08:05 Number three: sperm DNA fragmentation and the standard semen analysis 09:20 Number four: the full thyroid panel, including antibodies 10:20 The Embryo Audit Checklist 10:40 Number five: blood sugar and insulin, for both of you 11:45 Number six: inflammation, the gut microbiome, oxidative stress 12:40 Number seven: the ninety day window and why repeating a cycle repeats the result 13:45 Why the data driven approach works for left brain people 14:30 Chromosomal quality is information, not a verdict 14:55 The Functional Fertility Second Opinion WHAT THE RESEARCH SHOWS A standard semen analysis measures count, motility, and shape. It does not measure the integrity of the DNA inside the sperm. Sperm carrying damaged DNA can still fertilize an egg and produce a normal-looking embryo on day two or three, and development can stall after the genome handover. In a 2025 retrospective analysis of 870 fresh single blastocyst ICSI cycles, each one percent increase in sperm DNA fragmentation was associated with roughly 2.5 percent lower odds of obtaining a top quality blastocyst on day five. The same analysis found that fragmentation was not predictive of clinical pregnancy outcomes. It speaks to why an embryo stalled, not to whether a pregnancy will happen. Thyroid autoantibodies have been detected in follicular fluid at concentrations that correlate with blood levels, which is one reason a complete thyroid panel may include Free T3, Free T4, Reverse T3, TPO antibodies, and thyroglobulin antibodies rather than TSH alone. These are not established diagnostic tests for embryo arrest. They can provide context that a single TSH result cannot. THE EMBRYO AUDIT CHECKLIST If your embryos have arrested and you want to walk through what to review before the next cycle repeats the same result, we built the Embryo Audit Checklist for exactly this. Download it at https://fabfertile.com/pages/embryo-audit-checklist Or email hello@fabfertile.ca, subject line CHECKLIST. FUNCTIONAL FERTILITY SECOND OPINION This is a call where I review your cycle, your labs, your history, and your partner's picture together in one place. You leave knowing what your embryos may be telling you and what the next cycle would be built on, instead of repeating the same outcome. Whatever you decide afterward is yours, but it gets made with information your workup did not give you. Book at https://fabfertile.com/pages/book Or email hello@fabfertile.ca, subject line FERTILE. ABOUT THE HOST I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Subscribe to Get Pregnant Naturally for weekly episodes on fertility optimization, IVF preparation, and the lab work your doctor probably isn't running. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. If this episode helped you make sense of your own numbers, leave a review wherever you listen. It is how another woman, being told the same thing, finds her way here. REFERENCES Machałowski T, Machałowska J, Gill K, et al. Sperm DNA Fragmentation Impairs Early Embryo Development but Is Not Predictive of Pregnancy Outcomes: Insights from 870 ICSI Cycles. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167923 Monteleone P, Parrini D, Faviana P, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. American Journal of Reproductive Immunology. 2011. American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. 2020.

If you've seen headlines linking Ozempic and other GLP-1 medications to sudden eye strokes, I want to stop the panic right here.  In this episode, I break down what the research on NAION actually shows, who's really at risk, and why the scary relative-risk numbers you're seeing online don't tell the whole story. I walk you through what NAION is, why patients on semaglutide often already carry the underlying risk factors that get left out of the clickbait, and what the difference is between an observational study raising a signal and a randomized trial proving cause and effect. I also share the warning signs that mean you should go to the ER immediately, not wait for your next appointment. You'll walk away knowing exactly how to think about this headline, what questions to bring to your own doctor, and why staying on your medication is usually the right call. Episode Highlights: What NAION is and how it affects the optic nerve The risk factors patients on GLP-1s often already have What the 37-million-person study actually found — and didn't Why randomized trials tell a different story than observational data Absolute risk vs. relative risk, explained simply Warning signs that mean go to the ER now Why sleep apnea complicates the whole picture Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

In this episode of the DermSurgery Digest, you'll hear in-depth summaries and expert commentary on select cosmetic and general dermatology articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors Ardalan Minokadeh, MD, PhD, and Kristel Polder, MD, share key insights and perspectives on the articles: Practice Versus Protocol: A Survey of Current Botulinum Toxin Use During Lactation and Pregnancy in DermatologyEstablishing a Vocabulary for Skin Quality: Working Toward Consensus Skin Attribute Definitions From the Patient and Physician PerspectiveComparing a Red and Blue Light-Emitting Diode Light Device With an Existing Blue Light Device for At-Home Treatment of Inflammatory Acne: An Open-Label Randomized-Controlled TrialThis podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining cosmetic and general dermatology articles from the July issue are highlighted in a companion episode, Rapid Pearls, publishing on July 17, 2026.We welcome your feedback. Please contact communicationstaff@asds.net. 

In this episode of the DermSurgery Digest, you'll hear in-depth summaries and expert commentary on select surgical oncology and reconstruction articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors Kyle Lauck, MD, and Ally-Khan Somani, MD, PhD, EMBA, share key insights and perspectives on the articles: Increasing Mohs Micrographic Surgery Utilization in Darker Skin Phenotypes From 2011 to 2022Patient Satisfaction With Outcomes of Mohs Micrographic Surgery: A Prospective Cohort Study Using the Oxford Skin Cancer Treatment ScaleOptimization and Prevention of Error in Surgical Site IdentificationReducing Waste in Dermatologic Surgery: An Evidence-Based Review of Sustainability StrategiesThis podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining surgical oncology and reconstruction articles from the July issue are highlighted in a companion episode, Rapid Pearls, publishing on July 17, 2026.We welcome your feedback. Please contact communicationstaff@asds.net 

What if one of the most powerful tools to help cancer patients wasn't another medication—but movement?In this episode of The Breast Cancer Podcast, Dr. Mark Cripe and I sit down with one of the world's leading pioneers in Exercise Oncology, Dr. Jay Harness, to discuss why exercise is becoming an essential part of cancer care.We explore:

From Season 3 – Looking for time management strategies as an executive assistant or administrative professional? Learn from Harvard Business School professor Ashley Whillans to more effectively find, fund, and reframe your time. Recorded at EA Ignite Spring 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Johnny Mac shares five good news stories: A Washington police department found a mother bird nesting with four eggs inside a training motorcycle's storage compartment at its new headquarters and chose not to disturb it; two eggs have hatched. Researchers reported at the American Society of Clinical Oncology that the experimental pancreatic cancer pill D-A-R-A-X-O-N-R-A-S-I-B helped metastatic patients live a median 13.2 months versus 6.7 with chemotherapy, and studies are exploring earlier use. MIT researchers found ranking three options can reveal richer preference information than choosing between two, potentially improving AI recommendations and public services. In Louisiana, a real estate agent encountered an African eland antelope, possibly from a nearby game park. The Massachusetts Sport Authority set a Guinness record with a 47.9-foot soccer ball in East Boston.5 Good News Stories is a daily podcast with five positive, uplifting news stories to brighten your day. New episodes every day. Follow on Apple Podcasts, Spotify, or wherever you listen. Part of the Caloroga Shark Media networkJohn also hosts Daily Comedy NewsUnlock an ad-free podcast experience with Caloroga Shark Media!  For Apple users, hit the banner which says Uninterrupted Listening on your Apple podcasts app. Subscribe now for exclusive shows like 'Palace Intrigue,' and get bonus content from Deep Crown (our exclusive Palace Insider!) Or get 'Daily Comedy News,' and '5 Good News Stories' with no commercials! Plans start at $4.99 per month, or save 20% with a yearly plan at $49.99. Join today and help support the show!Get more info from Caloroga Shark Media and if you have any comments, suggestions, or just want to get in touch our email is info@caloroga.com

Dr. Martha Muñoz is an Assistant Professor in the Department of Ecology and Evolutionary Biology at Yale University. Martha is an evolutionary biologist who is working to better understand how and why evolution proceeds unevenly across the tree of life. Some features and branches of organisms evolve really quickly, while others remain inert or nearly inert for millions of years. Martha's research is uncovering the mechanisms underlying this phenomenon, and she has discovered that behavior is a key architect of evolution. For Martha, nature is a wonderful source of peace and inspiration for her research. When she's not working, she enjoys exploring the outdoors, hiking, seeing amazing views, and observing wildlife. She also spends her free time reading, going to museums, and visiting her family in New York City. She received her B.A. in biology from Boston University. Afterwards, Martha worked as a Fulbright Research Scholar at the National Museum of Natural Sciences in Madrid, Spain. She was awarded her Ph.D. in Organismic & Evolutionary Biology from Harvard University. Next, Martha conducted postdoctoral research in the Research School of Biology at The Australian National University and subsequently the Department of Biology at Duke University. Prior to accepting her current position at Yale University, Martha served on the faculty in the Department of Biological Sciences at Virginia Tech. Martha has received numerous awards and honors, including the Boston University Department of Biology's Distinguished Alumni 'Rising Star' Award, and a Young Investigator Award from the American Society of Naturalists. She was also named a 'Scientist to Watch' by The Scientist Magazine in 2019. In our interview, Martha shares more about her life and science.

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-american-studies

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/american-studies

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices

The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/book-of-the-day

A special one for us: we sat down with Sid Bhatnagar, CEO of ASQ, the American Society for Quality. Sid is an engineer and longtime technology executive who now leads the global body at the center of the quality profession, and he brought a sharp, practical view of how AI is reshaping what leadership requires.Sid and Nick get into why AI pressure now comes from boards and investors rather than the ground up, how to keep human judgment on both ends of the process, what executives owe their people through the change, and how to think about ROI when the technology won't sit still.A few of the takeaways:AI made the executive a steward of adoption and culture, not just a decision-maker, and the pressure is coming top downKeep humans on both ends: ideation from people, work from the tool, validation back to peopleLean toward critical decision-making, not tasks. Pilots and anesthesiologists get paid for what they know when things go wrongHire for innovation, change management, and system thinking. Lead by pulling people along, not pushingExecutives owe their teams upskilling; employees owe the effort. When there's no seat left, be transparent and generousYou can't retrofit ethics, and data isn't power, good data isThink about return on time, not just return on investment. Operations and customer service pay off fastest; talent is the long playAbout Sid BhatnagarSid Bhatnagar is CEO of ASQ, the American Society for Quality, a global organization with members in more than 130 countries. An engineer by training and a longtime technology executive and CIO across manufacturing and financial services, he joined ASQ in 2020 as CIO, became COO and Chief of Staff, and has led as CEO since 2023.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations. Learn more: https://www.thefdagroup.com/

A great public garden can change your whole day and sometimes your whole life. We sit down with Seth Hamby, Director of Living Collections at the Fort Worth Botanic Garden, to talk about the real work behind a place that feels effortless to visitors: the plant records, the people, the science, and the stories that turn a landscape into a living collection. We trace Seth's path into horticulture through volunteering, fieldwork, and conservation genetics, including research on an endemic Texas prairie clover and statewide genome collecting tied to the Smithsonian Global Genome Initiative for Gardens. Then we go behind the scenes at Fort Worth Botanic Garden as it earns the ASHS HortLandmark designation, exploring what makes it a standout public garden in the Dallas Fort Worth area, from the Rose Garden and famously peaceful Japanese Garden to a rainforest conservatory and seasonal Butterflies in the Garden.We also get practical about collections management including why GPS mapping matters and how a modern plant database supports research, education, and better visitor experiences. Seth also shares how volunteers help sustain the accredited Begonia collection and other details. We close with what we wish every student knew about careers in public horticulture, internships, and building opportunities by showing up consistently.Subscribe for more conversations on Plants, People, Science, then share this episode with a friend who loves botanic gardens and leave us a review. What's the public garden that always resets your brain?Learn more about Fort Worth Botanic Garden at https://fwbg.org/.Send us Fan MailLearn more about the American Society for Horticultural Science (ASHS) at  https://ashs.org/.HortTechnology, HortScience and the Journal of the American Society for Horticultural Science are all open-access and peer-reviewed journals, published by the American Society of Horticultural Science (ASHS). Find them at journals.ashs.org.Consider becoming an ASHS member at https://ashs.org/page/Becomeamember!You can also find the official webpage for Plants, People, Science at ashs.org/plantspeoplesciencepodcast, and we encourage you to send us feedback or suggestions at https://ashs.org/webinarpodcastsuggestion. Podcast transcripts are available at https://plantspeoplescience.buzzsprout.com.On LinkedIn find Sam Humphrey at linkedin.com/in/samson-humphrey. Curt Rom is at https://www.linkedin.com/in/curt-rom-611085134/. Lena Wilson is at https://www.linkedin.com/in/lena-wilson-2531a5141/.Thank you for listening!...

Justin Barr is a transplant surgeon at the Ochsner Clinic and a historian. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Podolsky, D.S. Jones, and J. Barr. Declarations of Independence — Physicians and the U.S. Body Politic, 1776–2026. N Engl J Med 2026;395:1-3.

Send us Fan MailThe COVID-19 pandemic proved vaccine platforms can move at unprecedented speed. It also revealed how dangerously narrow the world's response really was, built almost entirely on a single technology.Dr. Dan Barouch and Kris Brown, Co-Founders of Vector Sciences, join host David E. Williams to discuss why durable pandemic preparedness depends on having multiple vaccine platforms rather than just one, how their Rheovax platform uses mucosal immunity delivered through the nose to block transmission rather than just prevent severe disease, and why public trust in vaccines depends on being honest about what each technology can and cannot actually do.

Gut health trends are everywhere, but which ones deserve a closer look, and which ones need a reality check?In this episode, we break down the biggest gut health trends getting clicks, likes, and follows online. From our "hard no" to "I'm curious," we share where each trend lands on our hype scale and explain the science, physiology, and gut-brain connection behind our take.We explore what actually helps symptoms like constipation, bloating, and digestive discomfort without fueling anxiety, wasting money, or creating unnecessary health risks.From viral wellness trends to evidence-based advice, here's what we're discussing:Does the viral chia seed "internal shower" actually cleanse your colon or is that just clever marketing?Are colonics and coffee enemas detox heroes, or do they go against how your gut is designed to work?Can lemon water and apple cider vinegar really "wake up" your digestion first thing in the morning?Can a simple self-care routine improve your gut symptoms, even if it doesn't "heal" your digestive system?Are fermented foods always packed with probiotics or is there more to the story? (Tune in for a revisit of Episode 20!)Can you make colonoscopy prep more tolerable with "prep mocktails" without interfering with the procedure?Can you have too much of a good thing? What happens when "fibermaxxing" goes too far?Are gut-healing protocols and at-home microbiome tests helping you understand your gut or making you more confused and anxious?Do lactose intolerance patches actually work, or does the science tell a different story?Are castor oil packs a legitimate digestive therapy?Whether you're tempted to try the latest gut health hack or just wondering what's worth your attention, this episode will help you separate science from social media. Resources:Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders. Food Sci Nutr. 2022 Dec 15;11(1):3-16. doi: 10.1002/fsn3.3035.Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024. doi: 10.1093/cid/ciae104.Fermented Foods via ISAPPMisselwitz B, Butter M, Verbeke K, Fox MR. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut. 2019 Nov;68(11):2080-2091. doi: 10.1136/gutjnl-2019-318404. Epub 2019 Aug 19. PMID: 31427404; PMCID: PMC6839734.Learn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS.  The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment.  Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

Recorded live at the Food & Wine Classic in Aspen, Mark Pascal and Francis Schott sit down with four influential voices shaping American food and hospitality. Food & Wine Editor in Chief Hunter Lewis and chefs Claudette Zepeda, Cassidee Dabney, and Melissa Perello.Why You Should ListenHunter LewisWhy the Aspen Classic feels like “adult food and wine summer camp” and still makes even celebrated chefs bring their A game.How live events and genuine human connection offer something algorithms and AI cannot replicate.Claudette ZepedaHow growing up between Tijuana and San Diego shaped her expansive understanding of Mexican cuisine, migration, and cultural identity.Why authenticity is personal and how Cooking the Borderlands preserves the recipes and stories that might otherwise disappear.Cassidee DabneyHow Appalachian cooks transform seasonal necessity, preservation, and humble ingredients into deeply expressive cuisine.Why the future of luxury dining may be less about spectacle and more about thoughtful food, analog experiences, and being genuinely cared for.Melissa PerelloHow Frances and Octavia became enduring San Francisco neighborhood restaurants by building committed teams and lasting community relationships.Why restaurant longevity depends on consistency, evolution, and doing excellent work long after the opening-night attention has moved elsewhere.The GuestsHunter LewisHunter Lewis has served as Editor in Chief of Food & Wine since 2017. A former professional cook, he previously held senior editorial roles at Cooking Light, Southern Living, Bon Appétit, and Saveur. Under his leadership, Food & Wine has received honors from the James Beard Foundation, the IACP, and the American Society of Magazine Editors.Food & Wine https://www.foodandwine.com/Claudette ZepedaClaudette Zepeda is a San Diego–based chef, writer, television personality, and founder of Chispa Hospitality. Her cooking explores regional Mexican food and the cultural exchange found along the U.S.–Mexico border.Her debut cookbook, Cooking the Borderlands: Spice and Smoke Between Mexico and the States, combines personal stories with more than 100 recipes reflecting the intertwined communities and culinary traditions of the borderlands. Cassidee DabneyCassidee Dabney is Executive Chef of The Barn at Blackberry Farm in Walland, Tennessee. She joined Blackberry Farm in 2010 and became executive chef of The Barn in 2015.Her multicourse menus express Blackberry Farm's seasonal Foothills Cuisine, drawing from Appalachian traditions, the property's gardens, and regional farms. The Barn has received James Beard Awards for Outstanding Wine Program and Outstanding Service. Blackberry Farm, Walland, TNhttps://www.blackberryfarm.com/ Melissa PerelloMelissa Perello is the chef-owner of Frances and Octavia in San Francisco. A Culinary Institute of America graduate and former Food & Wine Best New Chef, she is known for seasonal California cooking that combines fine-dining technique with the warmth and accessibility of a neighborhood restaurant.Frances offers a rotating, ingredient-driven menu in a relaxed neighborhood setting, while sister restaurant Octavia presents Perello's modern California sensibility on a larger scale. Frances Restaurant, San Francisco, CAhttps://www.frances-sf.com/Timestamps1:00 Hunter Lewis: Why Aspen makes the food world bring its A game4:00 Live events, human connection, and what AI cannot replicate8:00 Claudette Zepeda: The multicultural food of Tijuana and the borderlands16:00 Preserving family recipes, defining authenticity, and cooking under pressure27:30 Cassidee Dabney: What defines Appalachian cuisine35:30 The future of luxury hospitality and making home cooking luxurious42:30 Melissa Perello: Building Frances and Octavia for the long haul51:30 Restaurant community, staff longevity, and the next chapter in San FranciscoIf you want a chance to get two tickets to our Bourbon, Beer & Beefsteak and live recording with Sother Teague and Jack McGarry in New Orleans on July 21, 2026,sign up to be a Restaurant Guys Regular (our paid subscribers) here  https://restaurantguysregulars.buzzsprout.com/ Then email TheGuys@restaurantguyspodcast.com. Put "beefsteak" in the subject line. We'll pick the winner and let you Subscribe: Restaurant Guys' Regularhttps://restaurantguysregulars.buzzsprout.com/Magyar Bankhttps://www.magbank.com/Stage Left Wine Shophttps://www.stageleftwineshop.com/Our PlacesStage Left Steakhttps://www.stageleft.com/Catherine Lombardi Restauranthttps://www.catherinelombardi.com/Stage Left Wineshophttps://www.stageleftwineshop.com/Reach Out to The Guys!TheGuys@restaurantguyspodcast.com

From Season 3 – Want to boost your leadership skills and impact? CEO and former executive assistant Tareka Wheeler reveals her strategies for leading with empathy and influence. Recorded at EA Ignite Spring 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

I hear this from so many of my patients: "Dr. Shelly, I haven't changed anything—not my diet, not my exercise—but I'm gaining weight and my body just doesn't respond the way it used to." If you're a woman in your 40s or 50s, you're probably nodding right now. In this episode, I'm walking you through exactly why menopause causes weight gain, why it has nothing to do with willpower, and what breakthrough new research reveals about Foundayo—an oral GLP-1 medication—and how it helps restore the biological signals that become harder to access during this life stage.  I'm sharing real data from the 2026 American Diabetes Association Scientific Conference, including results from the ATTAIN 1 and ATTAIN 2 clinical trials that show meaningful weight loss across all menopausal stages.  But here's what matters most: the goal during menopause isn't just weight loss—it's aging healthy. You'll learn exactly what that looks like and what you need to focus on right now. Episode Highlights: What menopause actually is ( How estrogen decline drives abdominal fat storage and insulin resistance Why muscle loss and poor sleep compound weight gain How GLP-1 medications work—and what they don't do The ATTAIN trials: weight loss results before, during, and after menopause Strength training, protein intake, and the non-negotiables for sustainable results REFERENCES: Menopausal Stage and Weight Outcomes with Orforglipron vs. Placebo: Post Hoc Subgroup Analysis from ATTAIN-1 and ATTAIN-2. Presented at the 86th Scientific Sessions of the American Diabetes Association, June 2026.   Horn DB, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist, for obesity treatment in adults with type 2 diabetes. Lancet. 2026.   ClinicalTrials.gov. ATTAIN-2 Trial (NCT05872620).   The Menopause Society. Menopause practice recommendations and patient resources on metabolic changes during menopause. Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Monongalia County Sheriff Todd Forbes on a wrong way driver overnight on I-68 in the Cheat Lake area. Tabitha Lafferre from Fairmont State University about the The American Society of Civil Engineers (ASCE) 2026 Civil Engineering Student Championships, hosted by Fairmont State University. Marion County Schools Superintendent Dr. Donna Heston on the recent review by the West Virginia Board of Education. Professor ameritus from the WVU School of Music on the 35th Independence Day Concert on the lawn of the Creative Arts Center July 4. 

Jamie Bay Nishi, the dynamic CEO of the American Society of Tropical Medicine and Hygiene (ASTMH), is absorbed with the question: how do we navigate all the changes in government policy and programs and hold the global health community together? That includes philanthropies, universities, and companies. OMB's proposed “Regulation for Federal Financial Assistance,” a 400-page document, would expand political oversight and weaken the authority of scientific advisory groups, changes that would alter the scientific research enterprise and create uncertainties. A 45-day period for comment is too little time to understand what is in the document and the ramifications if its proposed actions were enacted. It could further stigmatize collaboration with China. The June 3 White House Executive Order to reclassify the federal workforce will weaken career protections of GS-15 workers, leaving them open to firing at-will. CDC's overseas country offices are to transition to a fee-for-service model, as part of the America First Global Health Strategy. This will not be sufficient to guarantee a sustainable work force, which requires a reliable surge capacity in CDC headquarters at Atlanta and stable expert in-country staff. It is incumbent upon Congress to change the funding scheme for CDC overseas experts and its surge capability.

The Author Events Series presents Matt Haig | The Midnight Train In Conversation with Katy Waldman When your life flashes before your eyes, where would you stop? No one can change the past, but the Midnight Train can take you there. The chance to re-live the moments that meant most. To see what kind of person you really were. For Wilbur his best days were with Maggie, the love of his life. On his honeymoon in Venice. Before he gave it all away. He wishes he could go back and live differently. But to do so risks everything . . . A magical, time-travelling love story, from the world of The Midnight Library. Matt Haig is the #1 New York Times-bestselling author of the novels The Midnight Library, The Life Impossible, and How to Stop Time, along with four other novels, the acclaimed memoirs Reasons to Stay Alive and Notes on a Nervous Planet, and several award-winning children's books. His work has been published in fifty territories across the world. Katy Waldman is a staff writer at The New Yorker, for which she writes about books, culture, and more. Previously, she was a staff writer at Slate and the host of the ''Slate's Audio Book Club'' podcast. She won the National Book Critics Circle's Nona Balakian Citation for Excellence in Reviewing in 2019 and the American Society of Magazine Editors's award for journalists under thirty in 2018; her work has appeared in The New York Times, The Washington Post, New York magazine, the Paris Review, and elsewhere. She lives with her husband and dog in Washington, D.C. Because you love Author Events, please make a donation when you register for this event to ensure that this series continues to inspire Philadelphians. If you'd like to purchase two tickets but only one copy of the book, please email authorevents@freelibrary.org Books will be available for purchase at the library on event night! All tickets are non-refundable. (recorded 6/4/2026)

From Season 3 – Want to raise your confidence and resilience as an assistant? Take inspiration from guest Chynna Clayton, the former "body-woman" of First Lady Michelle Obama. Recorded at EA Ignite Spring 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Vascular access is the lifeline for people on dialysis. Today we'll cover the different types, how doctors determine the best option, what the surgery and recovery involve, and more! Today we're joined by Dr. Vandana Dua Niyyar, and kidney warrior Brittany Dickerson to discuss vascular access–an important topic that will hopefully help you all listening feel more informed and confident in your care.  In today's episode we heard from:  Vandana Dua Niyyar is Professor of Medicine in the Division of Nephrology and has received the Clinical Distinction of Master Physician at Emory University. Dr. Niyyar is passionate about promoting multidisciplinary collaboration in research and education in the field of vascular access; with the ultimate goal of optimizing access care and processes for dialysis patients. She currently serves as Immediate Past President of the American Society of Diagnostic and Interventional Nephrology (ASDIN). Dr. Niyyar has been recognized for her exemplary clinical and service achievements through various awards including ASDIN Distinguished Service Award in 2019, Emory Nanette Wenger Service Award in 2019, ASN Mid-Career Distinguished Clinical Service Award in 2020, ANIO Clinical Excellence Award in 2021, Emory DOM Outstanding Quality Achievement Award in 2022 and and ASDIN Gerald Beathard Award in recognition of her teaching excellence, scholarly activity, and clinical excellence in 2024. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.   Additional Resources Vascular Access Guidelines   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

As colorectal cancer rates rise among younger adults, surgeons are increasingly caring for patients with rectal cancer who are pregnant or hoping to preserve future fertility. With more individuals delaying childbearing, balancing effective cancer treatment with fertility preservation and maternal–fetal safety has become an important clinical challenge. This timely topic was recently highlighted by Dr. Sharon Suwanabol during a presentation at the American Society of Colon and Rectal Surgeons annual meeting 2026. In this episode, we explore the intersection of rectal cancer, fertility, and pregnancy through a multidisciplinary, case-based discussion. We review how surgery, chemotherapy, and pelvic radiation can affect fertility and sexual function in both men and women, and why early counseling and referral to reproductive endocrinology specialists are essential. The discussion also emphasizes that evaluation and treatment during pregnancy can often be performed safely, with care individualized based on tumor stage, gestational age, and the patient's goals and values. Hosts and discussants ·      Dr. Betelhem Yohannes, General surgery resident at the University of Washington ·      Dr. Griffen Allen, General surgery resident at the University of Washington  ·      Dr. Raga Siddharthan, Assistant Professor of Surgery in the Section of Colorectal Surgery at the University of Washington  ·      Dr. Stacey Cohen, Professor in the Division of Hematology and Oncology at the University of Washington and a gastrointestinal medical oncologist at Fred Hutch Cancer Center, specializing in colorectal and other GI cancers. Learning objectives ·      Describe the impact of rectal cancer surgery on fertility, sexual function, and future childbearing potential. ·      Review the effects of chemotherapy and pelvic radiation on reproductive health and fertility preservation. ·      Discuss available fertility preservation strategies and the importance of early pre-treatment counseling and referral. ·      Recognize the diagnostic challenges of rectal cancer during pregnancy, including overlapping gastrointestinal symptoms. ·      Review appropriate staging and workup considerations for suspected rectal cancer in pregnant patients. ·      Discuss multidisciplinary management strategies for rectal cancer during pregnancy, including individualized treatment sequencing. ·      Examine ethical and patient-centered considerations when balancing maternal cancer treatment and fetal outcomes. References  Siegel RL, Wagle NS, Star J, Kratzer TB, Smith RA, Jemal A. Colorectal cancer statistics, 2026. CA Cancer J Clin. 2026;76(2):e70067. doi:10.3322/caac.70067 [https://pubmed.ncbi.nlm.nih.gov/38240409/] Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11. Obstet Gynecol. 2022;140(2):348-366. doi:10.1097/AOG.0000000000004873 [https://pubmed.ncbi.nlm.nih.gov/35640237/] Stal J, YI SY, Cohen-Cutler S, et al. Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates. Oncologist. 2022;27(7):579-586. doi:10.1093/oncolo/oyac052 [https://pubmed.ncbi.nlm.nih.gov/35708892/] Druvefors E, Myrelid P, Andersson RE, Landerholm K. Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Disease: A National Cohort Study from Sweden. J Crohns Colitis. 2023;17(10):1631-1638. doi:10.1093/ecco-jcc/jjad079 [https://pubmed.ncbi.nlm.nih.gov/37341355/] Ito M, Tsukada Y, Watanabe J, et al. Long-term survival and functional outcomes of laparoscopic surgery for clinical stage I ultra-low rectal cancers located within 5 cm of the anal verge: A prospective phase II trial (Ultimate trial). Ann Surg. Published online April 1, 2024. doi:10.1097/SLA.0000000000006290 [https://pubmed.ncbi.nlm.nih.gov/38629555/] Teh WT, Stern C, Chander S, Hickey M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014;2014:482968.  Johnson GGRJ, Park J, Helewa RM, Goldenberg BA, Nashed M, Hyun E. Total neoadjuvant therapy for rectal cancer: a guide for surgeons. Can J Surg. 2023 Apr 21;66(2):E196-E201. doi: 10.1503/cjs.005822. PMID: 37085291; PMCID: PMC10125160. [https://pubmed.ncbi.nlm.nih.gov/37085291/] Naren G, Guo J, Bai Q, Fan N, Nashun B. Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. Expert Rev Mol Med. 2022 Jan 31;24:e9. doi: 10.1017/erm.2022.3. PMID: 35098910; PMCID: PMC9884763. [https://pubmed.ncbi.nlm.nih.gov/35098910/] National Comprehensive Cancer Network. (2026). NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (Version 2.2026). Retrieved from NCCN Guidelines for Rectal Cancer [https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1449] Oktay, Kutluk M.D., Ph.D.. Expert Commentary on Fertility Preservation in Colorectal Cancers: Current State and Practical Tips for the Cancer Practitioner. Diseases of the Colon & Rectum 63(6):p 726-727, June 2020. | DOI: 10.1097/DCR.0000000000001688 [https://pubmed.ncbi.nlm.nih.gov/32479532/] Stal J, YI SY, Cohen-Cutler S, et al. Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates. Oncologist. 2022;27(7):579-586. doi:10.1093/oncolo/oyac052 [https://pubmed.ncbi.nlm.nih.gov/35708892/] Gentile G, Ciccarone M. Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review. Curr Probl Cancer. 2025;57:101221. doi:10.1016/j.currproblcancer.2025.101221 [https://pubmed.ncbi.nlm.nih.gov/39598263/] Saif MW. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer. 2005;5(4):247-256. doi:10.3816/ccc.2005.n.035 [https://pubmed.ncbi.nlm.nih.gov/16183863/] Rogers JE, Dasari A, Eng C. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges. Oncologist. 2016 May;21(5):563-70. doi: 10.1634/theoncologist.2015-0362. Epub 2016 Mar 21. PMID: 27000464; PMCID: PMC4861360. [https://pubmed.ncbi.nlm.nih.gov/27000464/] Jiang Q, Hua H. Fertility in young-onset colorectal patients with cancer: a review. Oncologist. 2024;29(10):e1237-e1245. doi:10.1093/oncolo/oyae141 [https://pubmed.ncbi.nlm.nih.gov/39292850/] Dolmans MM, Hollanders de Ouderaen S, Demylle D, Pirard C. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet. 2015;32(8):1233-1237. doi:10.1007/s10815-015-0533-z [https://pubmed.ncbi.nlm.nih.gov/26162569/ Moawad NS, Santamaria E, Rhoton-Vlasak A, Lightsey JL. Laparoscopic Ovarian Transposition Before Pelvic Cancer Treatment: Ovarian Function and Fertility Preservation. J Minim Invasive Gynecol. 2017;24(1):28-35. doi:10.1016/j.jmig.2016.08.831 [https://pubmed.ncbi.nlm.nih.gov/27599763/] Fish R. Ovarian transposition in rectal cancer: uncertain benefit at a high price. Colorectal Dis. 2022;24(6):706-707. doi:10.1111/codi.16086 [https://pubmed.ncbi.nlm.nih.gov/35191146/] Ribeiro R, Baiocchi G, Moretti-Marques R, Linhares JC, Costa CN, Pareja R. Uterine transposition for fertility and ovarian function preservation after radiotherapy. Int J Gynecol Cancer. 2023;33(12):1837-1842. Published 2023 Dec 4. doi:10.1136/ijgc-2023-004723 [https://pubmed.ncbi.nlm.nih.gov/38104863/] Haggar F, Pereira G, Preen D, et al. Maternal and neonatal outcomes in pregnancies following colorectal cancer. Surg Endosc. 2013;27(7):2327-2336. doi:10.1007/s00464-012-2774-6 [https://pubmed.ncbi.nlm.nih.gov/23645367/] Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

You were told to try again. Maybe you were told it was bad luck, or to wait until it happened a third time before anyone would look. Here is what changed this year. In 2026, the American Society for Reproductive Medicine updated its definition of recurrent pregnancy loss for the first time since 2012. Two losses now meet the definition, not three, and a positive test that ended early counts. The old number kept women waiting for a third loss before the investigation even started. Here is the part no one tells you. Meeting the definition gets you a workup. It does not guarantee the workup is complete. After two or more losses, up to half of couples are told the same word. Unexplained. The losses are real. What gets called a complete workup is the question. This episode is the 9 specific things we most often find that are rarely checked before a woman is told her losses were unexplained or simply bad luck. Pull it up. Take notes. Bring it to your next appointment. The 9 patterns: Thyroid, the full panel and antibodies, not just TSH Antiphospholipid antibodies, tested correctly Chronic endometritis The reproductive microbiome, vaginal and seminal The gut, hidden gluten, and inflammation Sperm DNA fragmentation The male partner's full bloodwork Blood sugar and metabolic patterns The nervous system and progesterone These are the areas that sit outside a standard miscarriage workup. A 2012 meta-analysis in Human Reproduction, pooling sixteen studies and nearly three thousand couples, found miscarriage rates rose with sperm DNA damage, with about twice the relative risk. Unexplained rarely means there is nothing to find. It usually means the search stopped at the karyotype, one antiphospholipid test, the anatomy, and a TSH. For the full breakdown of every pattern, read the companion article, Recurrent Pregnancy Loss: The Functional Fertility Approach, at https://fabfertile.com/blogs/learn/recurrent-pregnancy-loss WHAT YOUR CLINIC MISSED The companion guide walks through all 9 of these patterns in more detail, so you can take it to your next appointment and ask the questions. Email hello@fabfertile.ca, subject line MISSED, and we will send you the guide. FUNCTIONAL FERTILITY SECOND OPINION A free 45-minute call where I review your labs, your history, your losses, and your partner's results with you. You leave knowing what your biology has been telling you and what your next decision could be. Email hello@fabfertile.ca, subject line FERTILE, or book here. ABOUT THE HOST I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. If this episode helped, leave a review on Apple Podcasts. It is how other women find this work. TIMESTAMPS 00:00 What "Unexplained" Means and What the 2026 Guideline Changed 01:30 Who's Reviewing Your Case at Fab Fertile 04:00 Thyroid: The Full Panel, Not Just TSH 05:50 Antiphospholipid Antibodies, Tested Correctly 06:30 Chronic Endometritis 07:30 The Reproductive Microbiome 08:30 The Gut, Hidden Gluten, and Inflammation 10:30 What Your Clinic Missed Guide 11:00 Sperm DNA Fragmentation 12:30 The Male Partner's Full Bloodwork 13:50 Blood Sugar and Metabolic Patterns 15:20 The Nervous System and Progesterone 16:30 What "Unexplained" Really Means 17:20 The Functional Fertility Second Opinion

A patient asked me this recently: "Dr. Shelley, I've heard that GLP-1 medications can cause muscle loss. Does that mean they can hurt my bones too?" It's an excellent question—and one we don't talk about nearly enough. In this episode, I'm walking you through what the research actually shows about GLP-1 medications and bone health, why weight loss itself poses a different risk to your skeleton, and the five non-negotiable steps you need to take to protect your bones while losing weight. This is the bone health conversation you need to hear before—or while—taking a GLP-1. Episode Highlights: What GLP-1 medications are and how they work in your body Does GLP-1 directly damage bones? What the research says The real issue: weight loss and how it affects bone health How your bones stay strong and why muscle matters Muscle loss during weight loss on GLP-1s (body composition breakdown) Who's at higher risk for weak bones and should be monitoring Eat enough protein: how much you actually need Strength training and resistance exercises for bone protection Getting enough calcium and vitamin D The DEXA bone density scan and when you should ask for one Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Mitchell E. Horwitz, MD, highlighted key developments and ongoing initiatives related to allogeneic and cord blood transplantations among patients with different hematologic malignancies. The conversation touched upon the impact of omidubicel-onlv (Omisirge) on patient outcomes, current research on reducing the risk of graft-vs-host disease (GVHD) among transplantation recipients, and strategies for providing effective prophylaxis during treatment, among other topics.

353. A MAN BECOMES WHAT HE THINKS ABOUT MOST OF THE TIME --Ralph Waldo Emerson ROBERT A. YOHO, MD. President, American Society of Cosmetic Breast Surgery, 2012-2013. Fellow, American Society of Cosmetic Breast Surgery. Passed specialty boards of American Board of Dermatologic Cosmetic Surgery and the American Board of Laser Surgery. Fellow of American Academy of Cosmetic Surgery and American Society of Cosmetic Breast Surgery. California Academy of Cosmetic Surgery, past board member. BIoidentical Hormone Therapy, WorldLinkMedical. Emergency Medicine Board Certified and recertified. AUTHOR: A New Body in One Day. Published over 20 articles for physicians in medical journals. CLIMBER. 24 hour ascents of both El Capitan and Half Dome. Free ascents Astroman, Crucifix. First ascents Yosemite, Joshua Tree, Devils Tower. EAGLE SCOUT. TRIATHLON participant and age group winner. Founder & Director NEW BODY COSMETIC SURGERY ~ Accreditation Association Ambulatory Health Care (AAAHC) Certified & Accredited Surgical/Medical Practice & New Body Cosmetic Surgery DrYoho.com Support the show

353. A MAN BECOMES WHAT HE THINKS ABOUT MOST OF THE TIME --Ralph Waldo Emerson ROBERT A. YOHO, MD. President, American Society of Cosmetic Breast Surgery, 2012-2013. Fellow, American Society of Cosmetic Breast Surgery. Passed specialty boards of American Board of Dermatologic Cosmetic Surgery and the American Board of Laser Surgery. Fellow of American Academy of Cosmetic Surgery and American Society of Cosmetic Breast Surgery. California Academy of Cosmetic Surgery, past board member. BIoidentical Hormone Therapy, WorldLinkMedical. Emergency Medicine Board Certified and recertified. AUTHOR: A New Body in One Day. Published over 20 articles for physicians in medical journals. CLIMBER. 24 hour ascents of both El Capitan and Half Dome. Free ascents Astroman, Crucifix. First ascents Yosemite, Joshua Tree, Devils Tower. EAGLE SCOUT. TRIATHLON participant and age group winner. Founder & Director NEW BODY COSMETIC SURGERY ~ Accreditation Association Ambulatory Health Care (AAAHC) Certified & Accredited Surgical/Medical Practice & New Body Cosmetic Surgery DrYoho.com Support the show

In this episode of the DermSurgery Digest, you'll hear quick, high-yield summaries with practical takeaways on the surgical oncology and reconstruction articles featured in the June 2026 issue of Dermatologic Surgery. Featured contributors this month are Tara Jennings, MD, and Bradley Merritt, MD.This podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining surgical oncology and reconstruction articles from the June issue are highlighted in-depth in a companion episode, Spotlight, published on June 12, 2026.We welcome your feedback. Please contact communicationstaff@asds.net.

From Season 2 – Do you have generational biases at work? Dr. Carrie Spell-Hansson shares how you can start challenging assumptions and having more meaningful conversations with colleagues across generations. Recorded at EA Ignite Fall 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Dr. Ashok K. Shetty is a University Distinguished Professor in the Department of Cell Biology and Genetics and Associate Director of the Institute for Regenerative Medicine at Texas A&M University, Naresh Vashisht College of Medicine. He is developing treatments for neurological and neurodegenerative disorders using stem cells and stem cell-derived products, such as extracellular vesicles. These are tiny vesicles secreted by stem cells that carry microRNAs and proteins. Once they make their way into the brain, they can induce beneficial changes in neural cells to improve brain function. Science takes up a lot of Ash's time, but when he's able to get a moment to himself, he enjoys spending time with family, cycling on a stationary bicycle, playing brain games like Sudoku, and going out to see movies at the theater. Ash earned his Ph.D. in Neuroscience from the All India Institute of Medical Sciences in New Delhi, and he completed postdoctoral research at Montana State University and Duke University. Afterward, he joined the faculty at Duke University in the Division of Neurosurgery. He joined the faculty at Texas A&M University College of Medicine in 2011. In 2024, he was honored with the University Distinguished Professor Award from Texas A&M University, and he has also received the College of Medicine's Senior Research Excellence Award. In addition, Ash is a Fellow of the American Association for the Advancement of Science and the American Society for Neural Transplantation and Repair. He has received the Research Career Scientist Award from the United States Department of Veterans Affairs, has been recognized among the "World's Top 1% of Scientists" across all scientific fields, and he was the 2025 honoree of Fast Company's World Changing Ideas. In this interview, Ash shares details about his life and his work in science.

Sixty thousand people a year get a procedure that could change their pain forever...and most have never heard of it.In this episode of Real Things Living, Brigitte Cutshall sits down with Dr. Steven Falowski, a neurosurgeon with nearly 20 years of experience who is helping lead the charge against chronic pain — without opioids. Dr. Falowski breaks down how spinal cord stimulation has evolved from bulky external battery packs to quarter-sized implants that quietly re-train your nervous system to stop feeling pain. From spine injuries and arthritis to migraines and post-surgical recovery, this conversation opens the door to a world of solutions most patients don't even know exist.3 Takeaways:(1) Pain is more common than heart disease, cancer, and diabetes combined — yet the tools to treat it effectively remain largely unknown to the public.(2) Spinal cord stimulators don't just block pain anymore — they re-register nerves to stop perceiving pain altogether.(3) New research is putting stimulators in at the time of spine surgery to prevent chronic pain before it even starts. If you or a loved one is silently navigating chronic pain, look beyond the pill bottle and research local pain specialists who utilize modern spinal cord stimulation. Explore trusted resources through the American Society of Pain and Neuroscience (ASPN) at https://aspnpain.com/Learn more about Dr. Falowski's practice at https://www.asclancaster.com/physicians/steven-m-falowski-md/

The FiltrateJoel Topf kidneyboy.bsky.socialSpecial GuestsDr. Samir Parikh, President of the American Society of NephrologyProf. Donal Reddan, President, Irish Nephrology SocietyProf. Catherine GodsonEditing Joel TopfThe Kidney Connection written and performed by Timothy YauShow Notes Tubular SecretionsJoel Topf, the Dublin Port Greenway LinkCatherine Godson: never heard of the Dublin Port GreenwaySamir Parikh: Trinity College Dublin and specifically the Eavan Boland Library, named after the Irish poet. Donal Reddan: Something about rugby

A 25-year-old pregnant woman presents with a 1-day history of progressive pain and swelling. The foot is cold, pulseless and neurologic function is deteriorating by the hour. Imaging shows a massive iliofemoral DVT. Now both the limb and the pregnancy are threatened. Do you anticoagulate, thrombolyse or operate? Join us as we break down the management and decision making behind this rare but devastating case.Hosts:·      Christian Hadeed -PGY 4 General Surgery, Brookdale Hospital Medical Center·      Paul Haser -Division Chief, Vascular Surgery, Brookdale Hospital Medical Center·      Andrew Harrington, Vascular surgery, Brookdale Hospital Medical Center·      Lucio Flores, Vascular surgery, Brookdale Hospital Medical CenterLearning objectives:-       Recognize the clinical presentation and pathophysiology of phlegmasia cerulea dolens-       Describe how pregnancy affects decision making in patients with phlegmasia and venous thromboembolic disease-       Discuss the goals of treatment for patients with DVT's and identify when operative intervention is indicated-       Describe the sequelae of DVT's and how this relates to post thrombotic syndrome-       Review the indications, risks, and limitations of anticoagulation, catheter-directed thrombolysis, thrombectomy, and fasciotomy in the management of DVT and phlegmasia.-       Explain the role of IVUS in managing venous thromboembolic disease and May Thurner syndromeReferences:-       Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C.-S., Kee, S., Schneider, J., … Kearon, C. (2017). Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine, 377(23), 2240–2252. https://doi.org/10.1056/NEJMoa1615066-       Gomes, M. S., Guimarães, M., & Montenegro, N. (2019). Thrombolysis in pregnancy: A literature review. Journal of Maternal-Fetal & Neonatal Medicine, 32(14), 2418–2428. https://doi.org/10.1080/14767058.2018.1438402-       Mangla, A., & Hamad, H. (2023). May-Thurner syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554377/-       Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Advances, 2(22), 3317–3359. https://doi.org/10.1182/bloodadvances.2018024802-       Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., et al. (2014). The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation, 130(18), 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 https://pubmed.ncbi.nlm.nih.gov/25246013/Sponsor URL: https://www.goremedical.com/If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

My interview with Steven begins at 28 minutes Watch and Subscribe to 6 Questions with Steven Beschloss Read and Subscribe to Steven Beschloss Writer, journalist, editor, filmmaker, professor For more than four decades, Steven Beschloss has created award-winning stories, as a writer, journalist, editor and filmmaker. Consistent in this work is a passion for writing and a belief in the transformative power of story. As a writer and journalist -- from the U.S. and Europe -- his writing on international and urban affairs, politics, economics, education, art and culture has been published by The New Yorker,  The Washington Post, The New York Times, The New Republic, Smithsonian, The Chicago Tribune, The Wall Street Journal, Parade Magazine, National Geographic, The Economist Intelligence Unit and dozens of other print and online outlets. He's been nominated for a Pulitzer Prize, selected Journalist of the Year in Virginia, and honored with a magazine writing award by the American Society of Journalists and Authors. He is the author of the narrative book, The Gunman and His Mother: Lee Harvey Oswald, Marguerite Oswald and The Making of an Assassin, a bestselling Amazon Kindle Single and newly updated and published by Open Road Media. He is also the co-author of Adrift: Charting Our Course Back to a Great Nation (Prometheus Books), a featured guest on MSNBC, Fox Business and NPR, and he writes and publishes America, America, a popular Substack newsletter focused on politics and society, democracy and justice. Beschloss is also an adjunct professor at New York University's Arthur L. Carter Journalism Institute. He was previously a professor of practice at Arizona State University, where he founded and directed the Narrative Storytelling Initiative and worked at the College of Global Futures and the Walter Cronkite School of Journalism and Mass Communication. At ASU, he also led narrative development, serving under the president's office. In addition to his work as a journalist, writing and editing for magazines and newspapers, Beschloss has taken on various roles as a scriptwriter, producer and director for film and television. His projects have included documentary and fiction films for European television, such as The Miracle, shot in Saint Petersburg, Russia, for the French-German ARTE channel and first screened at the Pompidou Centre in Paris. In 2003, he co-wrote and co-produced Paris, a noir thriller shot in Los Angeles and Las Vegas that premiered in competition at the Tribeca Film Festival, was acquired by 20th Century Fox Home Entertainment, sold to more than 20 countries, and aired for nearly two years on the Showtime movie channels. A Chicago native and married father of two daughters, Beschloss has lived and worked in New York, London, Helsinki, Moscow and Los Angeles.  He is a graduate of Haverford College, earned his master's degree at Northwestern University's Medill School of Journalis On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page Gift a Subscription https://www.patreon.com/PeteDominick/gift Send Pete $ Directly on Venmo All things Jon Carroll  Buy Ava's Art  Subscribe to Piano Tuner Paul Paul Wesley on Substack Listen to Barry and Abigail Hummel Podcast Listen to Matty C Podcast and Substack Follow and Support Pete Coe Hire DJ Monzyk to build your website or help you with Marketing

Join us in this episode as we explore the evolving field of cardiovascular medicine with Michael S. Sacks, Professor and Director of the James T. Willerson Center for Cardiovascular Modeling and Simulation at the University of Texas at Austin. As a leading expert in cardiovascular modeling, Professor Sacks focuses on developing patient-specific, simulation-based technologies that improve our understanding of heart and heart valve disease. What's his goal? To advance treatment strategies by helping physicians better predict outcomes and design therapies tailored to individual patients… Click play to learn about: The two major problems with valve therapy. How computational modeling is transforming the diagnosis and treatment of heart disease. Why patient-specific simulations may improve surgical planning and clinical outcomes. The limitations of current valve replacement technologies. Professor Sacks has held numerous leadership roles throughout his distinguished career, including serving as Technical Editor of the Journal of Biomechanical Engineering. He is an inaugural Fellow of the Biomedical Engineering Society, a Fellow of the American Society of Mechanical Engineers, and a Fellow of the American Institute for Medical and Biological Engineering. His honors include the Van C. Mow Medal from the ASME Bioengineering Division, the University of Pittsburgh Chancellor's Distinguished Research Award, the Richard Skalak Distinguished Lectureship from Columbia University, and the SKT Lectureship from the City College of New York. In 2006, he was recognized as one of Scientific American's 50 Leaders in Science and Technology. Connect with Professor Sacks:  LinkedIn University of Texas Profile  Google Scholar Profile Willerson Center for Cardiovascular Modeling and Simulation Oden Institute for Computational Engineering & Sciences